Dr. Hooman Djaladat, MD, MS
Professor of Clinical Urology | Urologic Oncologist | Medical Reviewer
Professional Biography
Dr. Hooman Djaladat, MD, MS, is a Professor of Clinical Urology at the Keck School of Medicine of the University of Southern California (USC). He specializes in urologic oncology, with clinical expertise in the diagnosis and surgical treatment of bladder, prostate, kidney, testicular, and other urological cancers.
His advanced training includes fellowships in endourology, laparoscopy, and urologic oncology. Dr. Djaladat has contributed extensively to medical research, with more than 220 peer-reviewed articles and book chapters, and has participated in clinical research aimed at improving cancer treatment and surgical outcomes.
Education and Qualifications
- Doctor of Medicine (MD): Tehran University of Medical Sciences, Iran, 2000.
- Residency in Urology: Sina Hospital, Tehran University of Medical Sciences, 2000–2004.
- Fellowship in Endourology and Laparoscopy: Labbafinejad Medical Center, Iran, 2007–2009.
- Fellowship in Urologic Oncology: University of Southern California, Los Angeles, 2010–2012.
- Master of Science (MS): Translational Research and Biomedical Investigation.
Areas of Expertise
- Urologic oncology
- Bladder cancer
- Prostate cancer
- Kidney and upper urinary tract cancers
- Testicular cancer
- Minimally invasive urological surgery
- Endourology and stone disease
- Robotic-assisted urological surgery
- Surgical management of complex urological cancers
- Clinical research in urologic oncology
Academic and Research Experience
Dr. Djaladat is a faculty member at the Keck School of Medicine of USC, where he contributes to clinical practice, medical education, and research. His research includes studies of urothelial carcinoma, bladder cancer surgery, robotic surgical techniques, and outcomes following treatment for urological malignancies.
He has authored numerous scientific publications and contributed to collaborative research projects examining cancer management, surgical outcomes, and evidence-based treatment strategies.
Selected Research Contributions
His research publications include work on:
- Surgical and oncological outcomes in upper tract urothelial carcinoma.
- Immune checkpoint inhibitor therapy in kidney cancer.
- Robotic-assisted surgery for urological malignancies.
- Outcomes and complications following radical cystectomy for bladder cancer.
- Diagnostic and prognostic approaches in urologic oncology.
Medical Reviewer Role at MindLiva
Proposed Position: Medical Reviewer — Urologic Oncology
Dr. Djaladat’s expertise is relevant to educational content concerning bladder, prostate, kidney, and testicular cancers, as well as urological surgery and cancer treatment. If he formally agrees to serve as a MindLiva reviewer, his role may include reviewing relevant articles for medical accuracy, scientific reliability, and clear communication of evidence-based information.